Immunogenic HER-2/neu peptides as tumor vaccines

During the last decade, a large number of tumor-associated antigens (TAA) have been identified, which can be recognized by T cells. This has led to renewed interest in the use of active immunization as a modality for the treatment of cancer. HER-2/neu is a 185-KDa receptor-like glycoprotein that is...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer Immunology, Immunotherapy Immunotherapy, 2006-01, Vol.55 (1), p.85-95
Hauptverfasser:	Baxevanis, Constantin N, Sotiriadou, Nectaria N, Gritzapis, Angelos D, Sotiropoulou, Panagiota A, Perez, Sonia A, Cacoullos, Nike T, Papamichail, Michael
Format:	Artikel
Sprache:	eng
Schlagworte:	Amino acids Animals Antigens Antigens, Neoplasm - immunology Breast cancer Cancer Vaccines - immunology Clinical Trials as Topic Cytotoxicity Disease Models, Animal Epitopes Glycoproteins Humans Immunotherapy Lymphocytes Neoplasms - immunology Neoplasms - therapy Ovaries Peptides Proteins Receptor, ErbB-2 - chemistry Receptor, ErbB-2 - immunology Symposium Paper T-Lymphocytes, Cytotoxic - immunology T-Lymphocytes, Helper-Inducer Vaccination Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!